Cure VCP Disease Inc (EIN 824368871) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

Nathan Peck

Phone

2294109573

Tax Period

2024-01-01 to 2024-12-31

Cure VCP Disease Inc, founded in 2018, is a small nonprofit in the Diseases & Disorders sector that reported $319K in total revenue in fiscal year 2024. Revenue fell 24% from the prior year — a significant decline worth monitoring. Expenses of $370K exceeded revenue, resulting in a 16% operating deficit.

Mission

Patient support and research for VCP Disease

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $278,868

Program Service Revenue $28,852

Investment Income $0

Other Revenue $11,074

TOTAL REVENUE $318,794

Expense Breakdown

Grants Paid $81,660

Salaries & Benefits $73,176

Fundraising Expenses $52,703

Program Expenses $276,430

Other Expenses $169,966

TOTAL EXPENSES $369,802

Year-over-Year Comparison

	2024	2023	Change
Revenue	$318,794	$421,071	-0.2%
Expenses	$369,802	$350,130	+0.1%
Net Income	$-51,008	$70,941	-1.7%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
NATHAN PECK	CEO	15.00	Officer Director	$0	$0	$0
ALLISON PECK	CFO	15.00	Officer Director	$0	$0	$0
AMY CASEY	SECRETARY	10.00	Officer Director	$0	$0	$0
KELLY GOLD	BOARD MEMBER	1.00	Director	$0	$0	$0
SARA BUHR	BOARD MEMBER	1.00	Director	$0	$0	$0
MAUREEN MCARTHUR HART	BOARD MEMBER	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$318,794	$369,802	$432,360	$-51,008
2023	$421,071	$350,130	$488,967	$70,941
2022	$326,027	$260,601	$406,811	$65,426
2021	$308,538	$142,075	$341,385	$166,463

Cure VCP Disease Inc